Providing robust, continuous, and remote real-time chemical sensors.

Weaving perfect components into quantum technology solutions.

Using bio-inspired hydropower systems to generate power which is then converted to electricity.

A new era in cancer therapeutics by developing personalised and targeted cancer treatments using the body's own immune system.

Harnessing the power of CRISPR to develop the next generation of RNA therapeutics.

Developing innovative therapeutics in oncology and behavioural brain disorders.

Developing treatments using molecularly targeted drugs tailored to the specific molecular profile of a patient's tumour.

Diagnostics built on a Raman-spectroscopy-powered single cell identification for bacteria and fungi.

Developing monoclonal antibodies for instant, long-lasting immunity, protecting vulnerable people from infectious diseases.

Commercialising T cell receptor-based immunotherapy for multiple indications.

Developing small-molecule drugs targeting cancer-linked disordered proteins.

A new approach to automatic speech recognition technology.

MatchBio's technology can improve the function of antigen receptors, for example by tuning their antigen sensitivity of their existing products.

The advancement, through pre-clinical and clinical trials, the development a number of lentiviral-based gene therapies for respiratory diseases.

All-in-one recruitment platform with video capacity.

Aims to identify and explore natural hydrogen sources.

Company developing a new gene therapy products for the treatment of rare diseases.

The company is focused on the use of bacteriocins and anti-microbial therapies.